Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERPARFUMS INCIPAR · Entity 4092 | Director | December 31, 2025 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERPARFUMS INC
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
After 2025-12-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2025-12-31 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
After 2025-12-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2025-12-31 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
After 2025-12-31 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-12-31 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
After 2025-12-31 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-12-31 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
After 2025-12-31 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-12-31 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 300 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2025 Filed Jan 5, 2026 21:32 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $84.64 | $0.00 |
DisclosureSEC source: 0001753926-26-000037 · form4.xml · derivative · entry 15 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2031-12-30 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:32 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $84.64 | $0.00 |
DisclosureSEC source: 0001753926-26-000037 · form4.xml · derivative · entry 14 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2031-12-30 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:32 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $84.64 | $0.00 |
DisclosureSEC source: 0001753926-26-000037 · form4.xml · derivative · entry 13 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2031-12-30 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:32 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $84.64 | $0.00 |
DisclosureSEC source: 0001753926-26-000037 · form4.xml · derivative · entry 12 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2031-12-30 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:32 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $84.64 | $0.00 |
DisclosureSEC source: 0001753926-26-000037 · form4.xml · derivative · entry 11 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2031-12-30 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $130.60 | $0.00 |
DisclosureSEC source: 0001753926-25-000007 · primary_doc.xml · derivative · entry 10 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2030-12-30 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $130.60 | $0.00 |
DisclosureSEC source: 0001753926-25-000007 · primary_doc.xml · derivative · entry 9 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2030-12-30 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $130.60 | $0.00 |
DisclosureSEC source: 0001753926-25-000007 · primary_doc.xml · derivative · entry 8 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2030-12-30 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $130.60 | $0.00 |
DisclosureSEC source: 0001753926-25-000007 · primary_doc.xml · derivative · entry 7 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2030-12-30 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $130.60 | $0.00 |
DisclosureSEC source: 0001753926-25-000007 · primary_doc.xml · derivative · entry 6 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2030-12-30 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:27 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $147.71 | $0.00 |
DisclosureSEC source: 0001753926-24-000035 · ownership.xml · derivative · entry 5 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2029-12-28 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:27 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $147.71 | $0.00 |
DisclosureSEC source: 0001753926-24-000035 · ownership.xml · derivative · entry 4 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2029-12-28 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:27 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $147.71 | $0.00 |
DisclosureSEC source: 0001753926-24-000035 · ownership.xml · derivative · entry 3 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2029-12-28 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:27 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $147.71 | $0.00 |
DisclosureSEC source: 0001753926-24-000035 · ownership.xml · derivative · entry 2 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2029-12-28 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:27 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 300 | $0.00 Strike: $147.71 | $0.00 |
DisclosureSEC source: 0001753926-24-000035 · ownership.xml · derivative · entry 1 Kappauf Gerard · CIK 0001990400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2029-12-28 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.